DK0948630T3 - Kloning og karakterisering af napsin, en asparaginprotease - Google Patents
Kloning og karakterisering af napsin, en asparaginproteaseInfo
- Publication number
- DK0948630T3 DK0948630T3 DK97948546T DK97948546T DK0948630T3 DK 0948630 T3 DK0948630 T3 DK 0948630T3 DK 97948546 T DK97948546 T DK 97948546T DK 97948546 T DK97948546 T DK 97948546T DK 0948630 T3 DK0948630 T3 DK 0948630T3
- Authority
- DK
- Denmark
- Prior art keywords
- napsin
- enzyme
- protease
- cloned
- expressed
- Prior art date
Links
- 108091005804 Peptidases Proteins 0.000 title abstract 3
- 239000004365 Protease Substances 0.000 title abstract 3
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title abstract 3
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 title 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 title 1
- 229960001230 asparagine Drugs 0.000 title 1
- 235000009582 asparagine Nutrition 0.000 title 1
- 238000012512 characterization method Methods 0.000 title 1
- 238000010367 cloning Methods 0.000 title 1
- 102000004190 Enzymes Human genes 0.000 abstract 5
- 108090000790 Enzymes Proteins 0.000 abstract 5
- 102000035101 Aspartic proteases Human genes 0.000 abstract 2
- 108091005502 Aspartic proteases Proteins 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 102000003908 Cathepsin D Human genes 0.000 abstract 1
- 108090000258 Cathepsin D Proteins 0.000 abstract 1
- 108010044467 Isoenzymes Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 238000003776 cleavage reaction Methods 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000002955 isolation Methods 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 210000005084 renal tissue Anatomy 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- 230000007017 scission Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3119696P | 1996-11-20 | 1996-11-20 | |
| US4612697P | 1997-05-09 | 1997-05-09 | |
| PCT/US1997/021684 WO1998022597A2 (en) | 1996-11-20 | 1997-11-20 | Cloning and characterization of napsin, an aspartic protease |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0948630T3 true DK0948630T3 (da) | 2008-08-11 |
Family
ID=26706937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97948546T DK0948630T3 (da) | 1996-11-20 | 1997-11-20 | Kloning og karakterisering af napsin, en asparaginprotease |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6225103B1 (enExample) |
| EP (1) | EP0948630B1 (enExample) |
| JP (2) | JP2001503643A (enExample) |
| AT (1) | ATE393227T1 (enExample) |
| AU (1) | AU734220B2 (enExample) |
| CA (1) | CA2271294A1 (enExample) |
| DE (1) | DE69738653T2 (enExample) |
| DK (1) | DK0948630T3 (enExample) |
| ES (1) | ES2308791T3 (enExample) |
| PT (1) | PT948630E (enExample) |
| WO (1) | WO1998022597A2 (enExample) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0897986A3 (en) * | 1997-08-21 | 2000-07-05 | Smithkline Beecham Corporation | Aspartic proteinase 5 (ASP5) |
| US7045333B1 (en) * | 1998-01-16 | 2006-05-16 | Incyte Corporation | Human protease molecules |
| US6203979B1 (en) | 1998-01-16 | 2001-03-20 | Incyte Pharmaceuticals, Inc. | Human protease molecules |
| US6432690B1 (en) | 1998-01-16 | 2002-08-13 | Incyte Genomics, Inc. | Human aspartic proteases |
| US7160679B1 (en) | 1998-05-21 | 2007-01-09 | Diadexus, Inc. | Method of diagnosing, monitoring, and staging lung cancer |
| JP2002520048A (ja) * | 1998-07-16 | 2002-07-09 | インサイト・ファーマスーティカルズ・インコーポレイテッド | ヒト・アスパラギン酸プロテアーゼ |
| EP1939297A1 (en) | 1998-09-24 | 2008-07-02 | Pharmacia & Upjohn Company LLC | Alzheimer's disease secretase |
| US7456007B1 (en) | 1998-12-31 | 2008-11-25 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
| US7115410B1 (en) * | 1999-02-10 | 2006-10-03 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
| WO2000047618A2 (en) | 1999-02-10 | 2000-08-17 | Elan Pharmaceuticals, Inc. | HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES |
| US7514408B1 (en) | 1999-12-02 | 2009-04-07 | Elan Pharmaceuticals, Inc. | β-secretase enzyme compositions and methods |
| JP2001172200A (ja) * | 1999-12-17 | 2001-06-26 | Meneki Seibutsu Kenkyusho:Kk | ヒトナプシンａに対する抗体およびこれを用いる医薬 |
| ATE343562T1 (de) | 2000-03-23 | 2006-11-15 | Elan Pharm Inc | Verbindungen und verfahren zur behandlung der alzheimerschen krankheit |
| AU2001267548A1 (en) * | 2000-06-26 | 2002-01-08 | Bayer Aktiengesellschaft | Regulation of human napsin-like aspartyl protease |
| US6846813B2 (en) | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
| CN1217920C (zh) | 2000-06-30 | 2005-09-07 | 艾兰制药公司 | 治疗早老性痴呆的化合物 |
| PE20020276A1 (es) | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| EP1666452A2 (en) | 2000-06-30 | 2006-06-07 | Elan Pharmaceuticals, Inc. | Compounds to treat Alzheimer's disease |
| EP1500663A1 (en) * | 2000-09-28 | 2005-01-26 | Eli Lilly And Company | Secreted proteins and their uses |
| US7806980B2 (en) * | 2000-12-23 | 2010-10-05 | Elan Pharmaceuticals, Inc. | Method for crystallizing human beta secretase in complex with an inhibitor |
| US7217556B1 (en) | 2000-12-23 | 2007-05-15 | Pfizer Inc | Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease |
| US7601528B1 (en) | 2000-12-23 | 2009-10-13 | Elan Pharmaceuticals, Inc. | Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease |
| US7384773B1 (en) * | 2001-05-10 | 2008-06-10 | Pfizer Inc | Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof |
| US7524668B1 (en) * | 2001-05-10 | 2009-04-28 | Elan Pharmaceuticals, Inc. | Crystal of human beta secretase having monoclinic space group symmetry C2 and methods for crystallization thereof |
| WO2002098849A2 (en) | 2001-06-01 | 2002-12-12 | Elan Pharmaceuticals, Inc. | Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases |
| US6906104B2 (en) | 2001-06-13 | 2005-06-14 | Pharmacia & Upjohn Company | Aminediols for the treatment of Alzheimer's disease |
| US6982264B2 (en) | 2001-06-27 | 2006-01-03 | Elan Pharmaceuticals, Inc. | Substituted alcohols useful in treatment of Alzheimer's disease |
| BR0211118A (pt) | 2001-07-10 | 2004-10-26 | Elan Pharm Inc | Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal |
| CA2453451A1 (en) | 2001-07-10 | 2003-01-23 | Elan Pharmaceuticals, Inc. | Aminediols for the treatment of alzheimer's disease |
| US7186539B1 (en) | 2001-08-31 | 2007-03-06 | Pharmacia & Upjohn Company | Method for refolding enzymes |
| EP1432674A2 (en) | 2001-10-04 | 2004-06-30 | Elan Pharmaceuticals, Inc. | Hydroxypropylamines |
| CA2466284A1 (en) | 2001-11-08 | 2003-05-15 | Elan Pharmaceuticals, Inc. | N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| DE60327250D1 (de) | 2002-02-21 | 2009-05-28 | Pharmacia & Upjohn Co Llc | Modifizierte bace |
| US7262208B2 (en) | 2002-04-30 | 2007-08-28 | Elan Pharmaceuticals, Inc. | Hydroxypropyl amides for the treatment of Alzheimer's disease |
| US7442537B1 (en) | 2002-05-10 | 2008-10-28 | Elan Pharmaceuticals, Inc. | Crystals of unliganded beta secretase and/or beta secretase-like proteins and the use thereof |
| WO2004009797A2 (en) * | 2002-07-23 | 2004-01-29 | Incyte Corporation | Protein modification and maintenance molecules |
| JP2006508166A (ja) | 2002-11-27 | 2006-03-09 | イーラン ファーマスーティカルズ、インコーポレイテッド | 置換尿素及びカルバメート |
| EP1615892A2 (en) | 2003-04-21 | 2006-01-18 | Elan Pharmaceuticals, Inc. | Benzamide 2-hydroxy-3-diaminoalkanes |
| EP1473362A1 (en) | 2003-05-02 | 2004-11-03 | Elan Pharmaceuticals, Inc. | Glycosylation variants of BACE |
| WO2005044977A2 (en) * | 2003-06-25 | 2005-05-19 | Diadexus, Inc. | Compositions, splice variants and methods relating to lung specific genes and proteins |
| WO2005087751A2 (en) | 2004-03-09 | 2005-09-22 | Elan Pharmaceuticals, Inc. | Substituted hydroxyethylamine aspartyl protease inhibitors |
| US20070292346A1 (en) * | 2004-03-25 | 2007-12-20 | Rong Fan | Lng105 Antibody Composition and Methods of Use, and Use of Lng105 to Assess Lung Cancer Risk |
| US7385085B2 (en) | 2004-07-09 | 2008-06-10 | Elan Pharmaceuticals, Inc. | Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors |
| WO2007047305A1 (en) | 2005-10-12 | 2007-04-26 | Elan Pharmaceuticals, Inc. | Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors |
| CA2687750C (en) | 2007-07-06 | 2016-10-18 | Boehringer Ingelheim International Gmbh | Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL107250A (en) * | 1993-10-12 | 2001-08-08 | Yeda Res & Dev | Dna molecules involved in programmed cell death, proteins encoded thereby and methods and compositions using said dna molecules and proteins |
| GB9618966D0 (en) * | 1996-09-11 | 1996-10-23 | Smithkline Beecham Plc | Novel compounds |
| US5776759A (en) * | 1996-09-26 | 1998-07-07 | Incyte Pharmaceuticals, Inc. | Two novel human cathepsin proteins |
-
1997
- 1997-11-20 PT PT97948546T patent/PT948630E/pt unknown
- 1997-11-20 ES ES97948546T patent/ES2308791T3/es not_active Expired - Lifetime
- 1997-11-20 US US08/974,691 patent/US6225103B1/en not_active Expired - Lifetime
- 1997-11-20 WO PCT/US1997/021684 patent/WO1998022597A2/en not_active Ceased
- 1997-11-20 DE DE69738653T patent/DE69738653T2/de not_active Expired - Lifetime
- 1997-11-20 DK DK97948546T patent/DK0948630T3/da active
- 1997-11-20 AU AU54592/98A patent/AU734220B2/en not_active Ceased
- 1997-11-20 JP JP52398598A patent/JP2001503643A/ja not_active Withdrawn
- 1997-11-20 AT AT97948546T patent/ATE393227T1/de active
- 1997-11-20 CA CA002271294A patent/CA2271294A1/en not_active Abandoned
- 1997-11-20 EP EP97948546A patent/EP0948630B1/en not_active Expired - Lifetime
-
2007
- 2007-11-15 JP JP2007297327A patent/JP2008118996A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998022597A2 (en) | 1998-05-28 |
| ATE393227T1 (de) | 2008-05-15 |
| JP2001503643A (ja) | 2001-03-21 |
| JP2008118996A (ja) | 2008-05-29 |
| AU5459298A (en) | 1998-06-10 |
| US6225103B1 (en) | 2001-05-01 |
| EP0948630B1 (en) | 2008-04-23 |
| ES2308791T3 (es) | 2008-12-01 |
| AU734220B2 (en) | 2001-06-07 |
| PT948630E (pt) | 2008-06-11 |
| DE69738653D1 (de) | 2008-06-05 |
| DE69738653T2 (de) | 2009-06-04 |
| WO1998022597A3 (en) | 1998-07-09 |
| CA2271294A1 (en) | 1998-05-28 |
| EP0948630A2 (en) | 1999-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0948630T3 (da) | Kloning og karakterisering af napsin, en asparaginprotease | |
| Fridman et al. | Domain structure of human 72-kDa gelatinase/type IV collagenase. Characterization of proteolytic activity and identification of the tissue inhibitor of metalloproteinase-2 (TIMP-2) binding regions. | |
| Nishiura et al. | The occurrence of an inhibitor of Ca2+-dependent neutral protease in rat liver | |
| Christensson et al. | Complex formation between protein C inhibitor and prostate‐specific antigen in vitro and in human semen | |
| Rosendahl et al. | Identification and characterization of a pro-tumor necrosis factor-α-processing enzyme from the ADAM family of zinc metalloproteases | |
| Xiao-Lan et al. | Purification and characterization of a novel fibrinolytic enzyme from Rhizopus chinensis 12 | |
| Shimamoto et al. | Partial characterization of an enzyme fraction with protease activity which converts the spore peptidoglycan hydrolase (SleC) precursor to an active enzyme during germination of Clostridium perfringens S40 spores and analysis of a gene cluster involved in the activity | |
| US5173403A (en) | Thermostable acid protease from sulfolobus acidocaldarius and gene | |
| WO1998022597A9 (en) | Cloning and characterization of napsin, an aspartic protease | |
| Cao et al. | Identification of a myofibril-bound serine proteinase (MBSP) in the skeletal muscle of lizard fish Saurida wanieso which specifically cleaves the arginine site | |
| WO1995030758A9 (en) | Recombinant hk2 polypeptide | |
| AU739546B2 (en) | Forms of prostate specific antigen and methods for their detection | |
| Yamauchi et al. | Recombinant and native zymogen forms of human complement factor D. | |
| Takahashi et al. | Purification and characterization of porcine kidney cathepsin B | |
| US4923818A (en) | DNA clone of human type IV collagenase | |
| CZ417897A3 (cs) | Lidský žlázový kallikrein-1 (hk2) | |
| Olalla et al. | Purification and properties of three proteases from the larvae of the brine shrimp Artemia salina | |
| JP2001503991A (ja) | 転移性前立腺癌の検出方法 | |
| JPH09235300A (ja) | ヒトｔｉｍｐ−３及び抗ヒトｔｉｍｐ−３モノクローナル抗体並びにその用途 | |
| GB2209526A (en) | DNA clone of human type IV collagenase | |
| JP4177253B2 (ja) | 細胞死抑制活性を有するペプチド断片を調製する方法 | |
| Mason et al. | Baculoviral expression and characterization of rodent cathepsin S | |
| Baker et al. | Purification and partial characterization of rat factor D | |
| AU2008202374B2 (en) | Genetically modified ecarin and process for producing the same | |
| Eleuteri et al. | Proteinase inhibitors of the Kunitz family in fallow deer organs: a comparative study |